MultiCell Technologies, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MultiCell Technologies, Inc.

MCET 0.000001000

-90.0%

Jun 6 1:41 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shawn Donahue who wrote (142)	1/8/2006 10:13:00 AM
From: Tradenride	of 237

Shawn, Tysabri(elan/biogen) is a 3 billion dollar drug and it reduced the rate of clinical relapses by up to 66% and reduced the development of new or newly enlarging MRI-detected brain lesions. MCT-125 reduces fatigue. $3 billion drug???? What a scam. If you read the patent for MCT-125 you will read that the drug would be most commonly effective for relieving fatigue for brain injury or stroke. Besides, MCET has no money to see this or any other project to fruition.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next